What is Dementia?
By 2031, greater than one in five Albertans will be aged 65 or older. Although dementia and cognitive decline is more common above age 65, there are also instances of early-onset dementia, affecting those in their 30s, 40s and 50s. Common symptoms of dementia and cognitive decline include challenges and memory lapses in language, communication skills, focus, and reasoning. Alzheimer’s disease is one form of dementia.
If you would like to contribute to further research on causes and treatments of dementia, please visit our donation page.
HBI dementia research has four focus areas: Early detection and monitoring, treatment and prevention, improving the lived experience, and mechanisms of cognitive decline and dementia, including clinical trials.
- Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future
An overview on the profound impact of COVID-19 upon older people with Alzheimer's disease and other dementias and the challenges encountered in our management of dementia in different health-care settings. Read the full article in the Journal of Alzheimer’s Association here.
- Dementia risk and prevention by targeting modifiable vascular risk factors
The incidence of dementia is expected to double in the next 20 years. The underlying aim should be to reduce microscopic brain tissue loss by modifying vascular and lifestyle risk factors over a relatively short period of time. Read the full article in the Journal of Neurochemistry here.
- Diagnosis, treatment and management of apathy in Parkinson's disease: a scoping review
This study conducted a scoping review of the literature on apathy in Parkinson's disease (PD), to better understand how apathy in Parkinson's disease is diagnosed, treated and managed. Read the full article at BMJ Open here.